Not exact matches
The researchers note that although the FDA in the past has treated all vaginal mesh implants as equivalent, the intervention rates for mesh - based complications in procedures for SUI appear to be lower than those
associated with procedures for pelvic
organ prolapse.
In that warning, the FDA also noted that transvaginal mesh devices used to treat pelvic
organ prolapse may present risks not
associated with more traditional non-mesh surgeries.
Boston Scientific's vaginal mesh products are meant to support
prolapsed organs and improve symptoms
associated with stress urinary incontinence (SUI) and pelvic
organ prolapse (POP).
This Food and Drug Administration classification means that complications
associated with transvaginal mesh are «not rare» and that there is no evidence proving that transvaginal mesh repair surgeries for pelvic
organ prolapse (POP) are more effective than traditional non-mesh repair.